Panacea Biotec Secures Govt Order for Bivalent Oral Polio Vaccine Worth ₹127.20 Crore

Panacea Biotec received a letter of acceptance from the Ministry of Health & Family Welfare to supply bivalent oral polio vaccine (bOPV) valued at ₹127.20 crore. The contract includes phased deliveries over 90 to 480 days, supporting India’s ongoing immunization initiatives under the Universal Immunization Programme. Analysts said the order reinforces Biotec’s position in the public health supply chain and highlights continued government focus on disease eradication and vaccine accessibility.